Abstract:It is known that low-frequency pulsed electromagnetic fields (PEMFs) can promote the differentiation and maturation of rat calvarial osteoblasts (ROBs) cultured in vitro.However,the mechanism that how ROBs perceive the physical signals of PEMFs and initiate osteogenic differentiation remains unknown.In this study,we investigated the relationship between the promotion of osteogenic differentiation of ROBs by 0.6 mT 50 Hz PEMFs and the presence of polycystin2(PC2) located on the primary cilia on the surface of ROBs.First,immunofluorescence staining was used to study whether PC2 is located in the primary cilia of ROBs,and then the changes of PC2 protein expression in ROBs upon treatment with PEMFs for different time were detected by Western blotting.Subsequently,we detected the expression of PC2 protein by Western blotting and the effect of PEMFs on the activity of alkaline phosphatase (ALP),as well as the expression of Runx-2,Bmp-2,Col-1 and Osx proteins and genes related to bone formation after pretreating ROBs with amiloride HCl (AMI),a PC2 blocker.Moreover,we detected the expression of genes related to bone formation after inhibiting the expression of PC2 in ROBs using RNA interference.The results showed that PC2 was localized on the primary cilia of ROBs,and PEMFs treatment increased the expression of PC2 protein.When PC2 was blocked by AMI,PEMFs could no longer increase PC2 protein expression and ALP activity,and the promotion effect of PEMFs on osteogenic related protein and gene expression was also offset.After inhibiting the expression of PC2 using RNA interference,PEMFs can no longer increase the expression of genes related to bone formation.The results showed that PC2,located on the surface of primary cilia of osteoblasts,plays an indispensable role in perceiving and transmitting the physical signals from PEMFs,and the promotion of osteogenic differentiation of ROBs by PEMFs depends on the existence of PC2.This study may help to elucidate the mechanism underlying the promotion of bone formation and osteoporosis treatment in low-frequency PEMFs.